Why the study?
Does implementation of a structured care protocol in a clinical trial setting reduce the rate of decline in renal function in Chinese type 2 diabetic patients with nephropathy?
Does implementation of a structured care protocol in a clinical trial setting reduce the rate of decline in renal function in Chinese type 2 diabetic patients with nephropathy?
Structured care protocols in clinical trials provide renoprotective effects through intensive risk factor management, independent of the investigational drug.
No takes yet. Share an insight, caveat, or question.
Structured care may slow renal decline in trial settings; leaves open generalizability to routine practice in diabetic nephropathy.
Leung et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: